Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

9 Meters Biopharma Inc (NMTR)

9 Meters Biopharma Inc (NMTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Where Superstar Investor David Tepper Has $5.1 Billion Invested Motley Fool - Thu Jan 4, 6:15AM CST

David Tepper has a stellar investing track record, and here's what he owns now.

MSFT : 431.20 (+0.05%)
QCOM : 162.58 (-0.28%)
INTC : 22.47 (-6.10%)
AMZN : 213.44 (+1.30%)
NVDA : 140.26 (+1.18%)
AMD : 141.98 (-0.06%)
GOOG : 173.02 (+0.02%)
TSM : 198.89 (+2.31%)
FDX : 282.85 (-4.66%)
BABA : 85.68 (-0.31%)
UBER : 71.27 (-2.46%)
NMTR : 0.0722 (-42.97%)
Corium Pharma Solutions Appoints Mark Sirgo as Chief Executive Officer Business Wire - Tue Jan 17, 2023

Corium Pharma Solutions, Inc. (“Corium Pharma Solutions” or “CPSI”), a leading, full-service contract development and manufacturing organization specializing in novel drug delivery technologies,...

PG : 175.42 (-2.38%)
AGRX : 1.5100 (unch)
NMTR : 0.0722 (-42.97%)
GNTA : 5.12 (-3.37%)
Wall Street - shutterstock_2763938
Pre-Market Brief: Stocks Rebound After Steep Losses Barchart - Tue Sep 27, 2022

December S&P 500 futures (ESZ22) are trending higher +1.11% this morning after three major US benchmark indices extended declines for the 5th consecutive session as investors continue to fret that higher...

ESZ22 : 3,871.47s (-0.66%)
NEXI.M.DX : 5.756 (+1.21%)
MARA : 25.13 (-1.95%)
HUT : 25.06 (-3.36%)
RIOT : 12.14 (+0.33%)
NMTR : 0.0722 (-42.97%)
ARDS : 0.0001 (unch)
NVDA : 140.26 (+1.18%)
NLS : 0.8204 (+11.20%)
KDP : 32.38 (-0.49%)
SNAP : 12.86 (+6.19%)
9 Meters Biopharma to Participate in the William Blair Biotech Focus Conference 2022 AccessWire - Wed Jul 6, 2022

RALEIGH, NC / ACCESSWIRE / July 6, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced...

NMTR : 0.0722 (-42.97%)
9 Meters Biopharma Announces Debt Facility to Support Phase 3 Study of Vurolenatide for Short Bowel Syndrome AccessWire - Thu Jun 30, 2022

Initial Draw of $20 Million to Support Funding Phase 3 Development of Vurolenatide in Short Bowel Syndrome

NMTR : 0.0722 (-42.97%)
9 Meters Biopharma Announces Positive Preliminary Results from Phase 2 Study of Vurolenatide in Short Bowel Syndrome AccessWire - Thu Jun 30, 2022

RALEIGH, NC / ACCESSWIRE / June 30, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced...

NMTR : 0.0722 (-42.97%)
9 Meters Biopharma Announces Interim Analysis of Phase 3 Study of Larazotide for Celiac Disease Does Not Support Trial Continuation AccessWire - Tue Jun 21, 2022

RALEIGH, NC / ACCESSWIRE / June 21, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced...

NMTR : 0.0722 (-42.97%)
9 Meters Biopharma to Participate in the 2022 BIO International Convention AccessWire - Mon Jun 13, 2022

RALEIGH, NC / ACCESSWIRE / June 13, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced...

NMTR : 0.0722 (-42.97%)
9 Meters Biopharma to Exhibit at Digestive Disease Week 2022 AccessWire - Thu May 19, 2022

RALEIGH, NC / ACCESSWIRE / May 19, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced...

NMTR : 0.0722 (-42.97%)
9 Meters Biopharma Presents Preclinical Data at the 2022 American Thoracic Society International Conference on the Use of Larazotide in Idiopathic Pulmonary Fibrosis AccessWire - Wed May 18, 2022

RALEIGH, NC / ACCESSWIRE / May 18, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced...

NMTR : 0.0722 (-42.97%)

Barchart Exclusives

Buy This High-Yield Dividend Stock That Looks Set to Shine Under Trump’s Presidency Barchart - Tue Dec 3, 6:30PM CST
Bank stocks have rallied after Donald Trump's election on hopes of favorable regulations under his tenure. With a dividend yield of over 3%, Citigroup looks like one bank stock to buy to bet on Trump's presidency. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot